Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers.
Rodabe N. Amaria(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Yvonne Gasior(The University of Texas MD Anderson Cancer Center), Ying Yuan(The University of Texas MD Anderson Cancer Center), Tyler Hilton(The University of Texas MD Anderson Cancer Center), Patrick Hwu(Moffitt Cancer Center), Anirban Maitra(NYU Langone Health), Emily Hinchcliff(The University of Texas MD Anderson Cancer Center), Cara Haymaker(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(BMC Software (United States)), Milind Javle(The University of Texas MD Anderson Cancer Center), Joseph Celestino(The University of Texas MD Anderson Cancer Center), Virginia Bayer(The University of Texas MD Anderson Cancer Center), Ching‐Wei D. Tzeng(The University of Texas MD Anderson Cancer Center), Karen H. Lu(The University of Texas MD Anderson Cancer Center), J. Andrew Livingston(The University of Texas MD Anderson Cancer Center), Anthony P. Conley(The University of Texas MD Anderson Cancer Center), Kelly M. Rangel(Cincinnati Children's Hospital Medical Center), Gauri R. Varadhachary(The University of Texas MD Anderson Cancer Center), Marie‐Andrée Forget(The University of Texas MD Anderson Cancer Center)
Cited by 6
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k